William W. Ericson - May 25, 2021 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Role
Director
Signature
/s/ Michele Farmer, Attorney-in-fact
Stock symbol
PACB
Transactions as of
May 25, 2021
Transactions value $
-$793,058
Form type
4
Date filed
5/26/2021, 08:50 PM
Previous filing
Apr 13, 2022
Next filing
Jun 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Options Exercise $132K +12.5K $10.58 12.5K May 25, 2021 Direct
transaction PACB Common Stock Options Exercise $45.8K +25K +200% $1.83 37.5K May 25, 2021 Direct
transaction PACB Common Stock Sale -$947K -36.6K -97.6% $25.88 900 May 25, 2021 Direct F1, F2
transaction PACB Common Stock Sale -$23.8K -900 -100% $26.42 0 May 25, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PACB Stock Option (right to buy) Options Exercise $0 -12.5K -100% $0.00* 0 May 25, 2021 Common Stock 12.5K $10.58 Direct F4
transaction PACB Stock Option (right to buy) Options Exercise $0 -25K -100% $0.00* 0 May 25, 2021 Common Stock 25K $1.83 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 18, 2021.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $25.37 to $26.36 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 This sale price represents the weighted average sale price of the shares sold ranging from $26.37 to $26.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4 The shares subject to the option are fully vested and exercisable.